Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem
Researcher: Dr. Galina Feinberg-Gorenshtein
Current Role & Affiliation
Title/Position: Deputy Director of the Hemato-Oncology Laboratories Institution: Schneider Children’s Medical Center of Israel
Email: galinafe1@clalit.org.il
Phone: 050-8583338
Dr. Feinberg-Gorenshtein specializes in developing advanced molecular diagnostics for pediatric cancers and plays a key role in laboratory management and quality assurance at Schneider Children’s Medical Center.
Research Focus
● Molecular diagnostics for pediatric cancers
● miRNA regulation in neuroblastoma
● Nanopore-based methylation sequencing
● Rapid classification of pediatric brain tumors
Current Projects Related to Pediatric Brain Tumors
● Developing rapid and precise classification methods for pediatric brain tumors
● Application of Nanopore-based methylation sequencing from FFPE samples
Laboratory/Research Resources
● Molecular oncology diagnostic platforms
● Advanced sequencing and biomarker analysis tools
Collaboration Interests
● Precision medicine in pediatric oncology
● Advanced molecular diagnostics
What You Can Offer Potential Collaborators
● Expertise in molecular diagnostics and sequencing
● High-quality laboratory management and quality assurance expertise
Keywords
Molecular Oncology, Pediatric Cancers, Methylation Sequencing, Neuroblastoma, Precision Medicine
Brief Bio
Dr. Galina Feinberg-Gorenshtein is the Deputy Director of the Hemato-Oncology Laboratories at Schneider Children’s Medical Center of Israel. With over 25 years of experience in molecular oncology, she specializes in developing advanced molecular diagnostics for pediatric cancers. Dr. Feinberg-Gorenshtein earned her PhD from the Sackler Faculty of Medicine at Tel Aviv University, where she investigated the role of miRNAs in regulating the ALK gene in neuroblastoma. Her research focuses on innovative methods for the rapid and precise classification of pediatric brain tumors using Nanopore-based methylation sequencing from FFPE samples. In addition to her research, she plays a key role in laboratory management and quality assurance, ensuring the highest standards in diagnostic testing. She has presented her work at national and international conferences and remains committed to advancing precision medicine in pediatric oncology.
